PL1457497T3 - Sposób usuwania wirusów obecnych w roztworach fibrynogenu - Google Patents

Sposób usuwania wirusów obecnych w roztworach fibrynogenu

Info

Publication number
PL1457497T3
PL1457497T3 PL04380045T PL04380045T PL1457497T3 PL 1457497 T3 PL1457497 T3 PL 1457497T3 PL 04380045 T PL04380045 T PL 04380045T PL 04380045 T PL04380045 T PL 04380045T PL 1457497 T3 PL1457497 T3 PL 1457497T3
Authority
PL
Poland
Prior art keywords
removing viruses
fibrinogen solutions
fibrinogen
solutions
viruses
Prior art date
Application number
PL04380045T
Other languages
English (en)
Inventor
Debart Pere Ristol
Rodriguez Jesus Fernandez
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of PL1457497T3 publication Critical patent/PL1457497T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL04380045T 2003-03-06 2004-03-03 Sposób usuwania wirusów obecnych w roztworach fibrynogenu PL1457497T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200300538A ES2214967B1 (es) 2003-03-06 2003-03-06 Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
EP04380045A EP1457497B1 (en) 2003-03-06 2004-03-03 Process for removing viruses in fibrinogen solutions

Publications (1)

Publication Number Publication Date
PL1457497T3 true PL1457497T3 (pl) 2009-06-30

Family

ID=32749109

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04380045T PL1457497T3 (pl) 2003-03-06 2004-03-03 Sposób usuwania wirusów obecnych w roztworach fibrynogenu

Country Status (15)

Country Link
US (2) US7442308B2 (pl)
EP (1) EP1457497B1 (pl)
JP (1) JP4272562B2 (pl)
AR (1) AR043238A1 (pl)
AT (1) ATE410438T1 (pl)
AU (1) AU2004200745B8 (pl)
BR (1) BRPI0400375B8 (pl)
CA (1) CA2459690C (pl)
CL (1) CL2004000261A1 (pl)
DE (1) DE602004016900D1 (pl)
ES (2) ES2214967B1 (pl)
MX (1) MXPA04001829A (pl)
NZ (1) NZ531328A (pl)
PL (1) PL1457497T3 (pl)
PT (1) PT1457497E (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US20120177610A1 (en) * 2007-09-19 2012-07-12 Kieu Hoang Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
CA2709781C (en) 2007-12-28 2017-03-14 Baxter International Inc. Counter-pressure filtration of proteins
CA2742817A1 (en) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
EP2412817B2 (en) * 2009-03-27 2019-06-05 Asahi Kasei Medical Co., Ltd. Method for removing viruses in high-concentration monoclonal antibody solution
EP2619225B1 (en) 2010-09-20 2016-06-15 Octapharma AG Process for production of fibrinogen
US10112972B2 (en) 2012-03-13 2018-10-30 Octapharma Ag Process for production of fibrinogen and fibrinogen produced thereby
MX386767B (es) * 2012-06-21 2025-03-19 Takeda Pharmaceuticals Co Filtración de virus de medio de cultivo celular.
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
EP3154597B1 (en) 2014-06-12 2019-01-30 Biosyn Arzneimittel GmbH Preparation methods for a novel generation of biological safe klh products used for cancer treatment, for the development of conjugated therapeutic vaccines and as challenging agents
EP3154578B1 (en) 2014-06-12 2019-01-02 Biosyn Arzneimittel GmbH Preparation methods for a novel generation of biological safe klh products used for cancer treatment, for the development of conjugated therapeutic vaccines and as challenging agents
KR101841587B1 (ko) * 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
EP3498828B1 (en) * 2016-08-09 2021-11-03 Asahi Kasei Medical Co., Ltd. Method for treating solution contaminated with porcine circoviruses
FR3090321B1 (fr) 2018-12-21 2023-07-14 Lab Francais Du Fractionnement Procédé de filtration du fibrinogène
CN111848783B (zh) * 2020-07-29 2023-07-04 同路生物制药有限公司 一种人纤维蛋白原的制备方法
WO2022133973A1 (en) * 2020-12-25 2022-06-30 Guangzhou Bioseal Biotech Co., Ltd. Fibrinogen aseptic filtration
JP7645133B2 (ja) * 2021-06-04 2025-03-13 Ｋｍバイオロジクス株式会社 血液凝固第ｘｉｉｉ因子を含むフィブリノゲンの製造方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US511154A (en) * 1893-12-19 Feed-gage for printing-presses
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
FR2563357B1 (fr) * 1984-04-18 1987-12-04 Cormier Bernard Panneau de signalisation routiere
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
JP3867931B2 (ja) * 1993-11-08 2007-01-17 財団法人化学及血清療法研究所 液状フィブリノゲン製剤
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography
EP0860444A1 (en) 1997-02-24 1998-08-26 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis (CLB) Method for removing viruses from a protein solution
US5981254A (en) * 1997-10-30 1999-11-09 Haemacure Corporation Process for producing thrombin from plasma
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
ES2156731B1 (es) * 1999-05-31 2002-02-16 Grifols Grupo Sa Utilizacion del acido tranexamico para la preparacion de una composicion de fibrinogeno humano.
US6270672B1 (en) * 1999-08-06 2001-08-07 Baxter Aktiengesellschaft Devices and methods for removing pathogens from biological fluids
US6867285B2 (en) * 1999-12-20 2005-03-15 Mitsubishi Pharma Corporation Virus-free plasma protein compositions treated with porous membrane and process for producing the same
DE10022092A1 (de) * 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
JP2001335509A (ja) * 2000-05-31 2001-12-04 Nihon Pharmaceutical Co Ltd フィブリノーゲンを含有する溶液のウイルス除去法
IL136552A (en) 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration

Also Published As

Publication number Publication date
US20040173527A1 (en) 2004-09-09
ES2214967B1 (es) 2005-06-16
EP1457497A1 (en) 2004-09-15
BRPI0400375B8 (pt) 2021-05-25
EP1457497B1 (en) 2008-10-08
MXPA04001829A (es) 2004-09-08
JP2004269529A (ja) 2004-09-30
US7442308B2 (en) 2008-10-28
AU2004200745B2 (en) 2008-07-03
ES2312944T3 (es) 2009-03-01
BRPI0400375A (pt) 2005-01-04
AR043238A1 (es) 2005-07-20
BRPI0400375B1 (pt) 2018-05-08
US20080274974A1 (en) 2008-11-06
CA2459690A1 (en) 2004-09-06
AU2004200745A1 (en) 2004-09-23
AU2004200745B8 (en) 2009-01-08
CL2004000261A1 (es) 2005-03-18
NZ531328A (en) 2004-10-29
ES2214967A1 (es) 2004-09-16
DE602004016900D1 (de) 2008-11-20
CA2459690C (en) 2010-11-02
ATE410438T1 (de) 2008-10-15
JP4272562B2 (ja) 2009-06-03
PT1457497E (pt) 2008-12-10

Similar Documents

Publication Publication Date Title
PL1457497T3 (pl) Sposób usuwania wirusów obecnych w roztworach fibrynogenu
EG24449A (en) Purification process
IL175261A0 (en) Cleaning solutions and etchants and methods for using same
SG115856A1 (en) Process solutions containing surfactants
EP1633321A4 (en) METHOD FOR CLEANING VIRUS
GB0324947D0 (en) Process
GB0322640D0 (en) Process
GB0304726D0 (en) New Process
EP1825008B8 (en) Treatment process for bars
GB0307259D0 (en) Process
GB0317257D0 (en) Improved detergent bar and process for manufacture
IL176293A0 (en) Treatment process for industrial waste stream
NO20035180D0 (no) Prosessforbedringer i stereokjemi
EP1701920A4 (en) METHOD FOR TREATING SUSTAINABLE SOLUTIONS
TWI350829B (en) Purification process
GB0321240D0 (en) Process
GB0313031D0 (en) Process
GB0217417D0 (en) Process for treating waste
AU2002335255A1 (en) Method and apparatus for removing ion present in solution by the crystallization method
FI20035176A0 (fi) Menetelmä siistausprosessissa
HU0301629D0 (en) Process for mending
HU0300439D0 (en) Process for mending
GB2410213B (en) Cleaning blade and process for its manufacture
AU2003280224A1 (en) Radioactive species removal process
GB0314380D0 (en) Purification process